Leadership & Pay ·
Veraxa Biotech appoints Raju Willener as CFO and principal accounting officer
VRXAVeraxa Biotech AG - Post de-SPAC
Veraxa Biotech AG appointed Raju Willener as Chief Financial Officer and principal accounting officer, effective September 4, 2026. Mr. Willener brings over three decades of international experience in investment banking, corporate finance, and asset management, having previously served as CFO at Exentis Group AG. He succeeds Carl von Halem, who is thanked for his support. Veraxa Biotech AG operates in the biotechnology industry, developing next-generation antibody-based cancer therapies.